Signal active
Investment Firm
Overview
Sangon Biotech Co. (生工生物) is engaged in the research and development of chemical synthesis of DNA.
It is a high-tech Sino-foreign joint venture established in 2003. After ten years of development, Sangon has become a professional biotechnology company that integrates research and development. Chemical synthesis DNA earned reputation for Sangon in the global market.
In 2006, Sangon invested 50 million to build a manufacturing and industrial base in Songjiang Industrial Park, which has been put into use. Sangon produces various products such as DNA synthesis, DNA sequencing, Gene Synthesis, peptide synthesis, chemical agents, enzymes, molecular biology kit, cultivation medium, lab consumptive material, and miniature instruments.
Highlights
2003
Biotechnology
1001-5000
2
0
undefined
Seed
N/A
Location
Asia
Contact Information
Social
Profile Resume
Sangon Biotech, established in 2003 and headquartered in Asia., specializes in Seed investments across Biotechnology, Health Care, Medical, Product Research, Service Industry, Medical Device. Their recent investments include Youlong Biotech, yikexue.com. The highest investment round they participated in was $25.3M. Among their most notable exits are Youlong Biotech and yikexue.com. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
2
0
0
undefined
Investments
2
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jun 20, 2016 | Youlong Biotech | Biotechnology | 455.8K |
Jul 01, 2016 | yikexue.com | Service Industry | 1.5M |
Exits
0
Funding Timeline
2
9
0
Funding Rounds
2
Sangon Biotech has raised 2 rounds. Their latest funding was raised on Jul 01, 2016 from a Seed Round - yikexue.com round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jun 20, 2016 | Angel Round - Youlong Biotech | - | 455.8K | - |
Jul 01, 2016 | Seed Round - yikexue.com | - | 1.5M | - |
Investors
9
Sangon Biotech is funded by 9 investor(s). Novo Holdings and Huagai Capital Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
CPE | No | Venture Round - Sangon Biotech | 290.4M |
GL Capital | Yes | Venture Round - Sangon Biotech | 290.4M |
Huagai Capital | No | Venture Round - Sangon Biotech | 290.4M |
Novo Holdings | No | Venture Round - Sangon Biotech | 290.4M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.